Metoclopramide Injection, Solution
Product Images NDC 51662-1670

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoclopramide (NDC 51662-1670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51662 1670 1 Rfid)

Label (51662 1670 1 Rfid)
A drug packaging label with encoded numerical identifiers and a 2D barcode on the upper right. The label includes text instructing to see the manufacturer's insert. It states distribution by HF Acquisition Co., LLC located in Mukilteo, WA 98275. The label does not show specific product name, strength, or dosage form details visibly but matches the description of Metoclopramide injection distributed by the same company.*
FDA Label Image

Structure (51662 1670 1 Structure)

Structure (51662 1670 1 Structure)
Chemical structure of metoclopramide hydrochloride monohydrate, showing its molecular formula with chlorine, amino, methoxy, and diethylaminoethyl groups. The molecular weight is listed as 354.3.*
FDA Label Image

Table (51662 1670 1 Table 1)

Table (51662 1670 1 Table 1)
A table presenting adult pharmacokinetic data for a drug, including parameters such as volume of distribution (Vd), plasma protein binding percentage, half-life (t1/2) in hours, and oral bioavailability percentage with variability.*
FDA Label Image

Table (51662 1670 1 Table 2)

Table (51662 1670 1 Table 2)
A data table titled 'Pediatric Pharmacokinetic Studies' presenting pharmacokinetic parameters such as dose, absorption half-life (t1/2a), clearance (Cl), volume of distribution (Vd), and peak serum concentration (Cmax) from two studies of metoclopramide with varying doses and routes in pediatric patients. The table includes references for the studies cited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.